Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma (Q41650259)

6 October 2017

title

Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma (English)

1 reference

6 October 2017

0 references

Murono S

1 reference

6 October 2017

Yoshizaki T

series ordinal

1 reference

6 October 2017

Park CS

series ordinal

1 reference

6 October 2017

Furukawa M

series ordinal

1 reference

6 October 2017

publication date

1 May 1999

1 reference

6 October 2017

1 reference

6 October 2017

1 reference

6 October 2017

1 reference

6 October 2017

page(s)

432-438

1 reference

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Determination of nonendemic nasopharyngeal carcinoma by in situ hybridization for Epstein-Barr virus EBER1 RNA: sensitivity and specificity in cervical node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Tumourigenesis associated with the p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Targeting frequency for deletion vectors in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00625.X

10.1046/J.1365-2559.1999.00625.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference